VitalTrax, LLC.

VitalTrax, LLC. specializes in enhancing patient engagement in clinical research through innovative enrollment solutions that connect patients with relevant clinical trials. Founded in 2016, VitalTrax, LLC. is located in Philadelphia, US.

The company focuses on patient enrollment for clinical trials, with its latest funding round being a Seed investment of USD 0. 15 million obtained on March 22, 2017, from Ben Franklin Technology Partners, Independence Health Group, and Safeguard Scientifics. Zikria Syed serves as the CEO, leading the company with a vision to streamline patient recruitment processes in clinical research. VitalTrax offers a comprehensive suite of services aimed at facilitating patient enrollment in clinical research studies.

Their core offerings include a direct-to-patient enrollment approach that connects patients with clinical trials tailored to their specific health conditions, such as scleroderma, rheumatoid arthritis, and Sjögren’s syndrome. The platform serves a diverse clientele, including patients, healthcare providers, and clinical research organizations (CROs) across North America and Europe, fostering supportive patient communities and sharing inspiring patient stories to enhance engagement in clinical research. VitalTrax generates revenue through partnerships and contracts with clinical research organizations, pharmaceutical companies, and healthcare providers. Their business model primarily focuses on B2B transactions, where sponsors and CROs utilize VitalTrax's services to enhance enrollment capabilities for clinical trials.

The company employs a subscription-based pricing model or fee-for-service structure, charging clients based on the number of patients enrolled or the level of service provided, ensuring a tailored approach to meet the specific needs of their clients. In March 2017, VitalTrax raised USD 0. 15 million in Seed financing to support its future growth initiatives. The company plans to expand its offerings by developing new products designed to enhance patient engagement and streamline enrollment processes.

Additionally, VitalTrax aims to target new geographic markets, focusing on expanding its presence in Europe and North America by the end of 2023.